Taysha Gene Therapies (TSHA) Interest & Investment Income (2023 - 2026)
Taysha Gene Therapies (TSHA) posted Interest & Investment Income of $2.33 million for Q2 2026, up 25.1% from $1.86 million a year earlier but down 10.1% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Taysha Gene Therapies was $10.95 million, up 56.6% year-over-year; for FY2025, it came in at $9.22 million, up 32.9% from FY2024.
- In prior years, Taysha Gene Therapies' Interest & Investment Income was $6.94 million in FY2024 (+94.3%) and $3.57 million in FY2023.
- Quarterly Interest & Investment Income has run from a low of $1.11 million in Q3 2023 to a high of $3.17 million in Q3 2025 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last five quarters, with growth averaging 40.7% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2026, with growth of 95.0%; the weakest was Q1 2025, with a decline of 21.7%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $2.59 million (Q1 2026), $2.87 million (Q4 2025) and $3.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Taysha Gene Therapies | 1.51 Bn | 1.51 Bn | - | 2.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.87 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.11 Mn |
API Access
Taysha Gene Therapies Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();